Literature DB >> 33496298

The role of coordination compounds in virus research. Different approaches and trends.

Noelia Maldonado1, Pilar Amo-Ochoa2.   

Abstract

This article aims to provide an overview of the studies focused on using coordination compounds as antiviral agents against different types of viruses. We present various strategies so far used to this end. This article is divided into two sections. The first collects the series of designed antiviral drugs based on coordination compounds. This approach has been developed for many years, starting from the 70s with the discovery of cis-platin (cis-DDP). It has been mainly focused on studying the synergistic effect of a wide variety of new compounds obtained by combining metal ions with organic antiviral ligands. Then, we collect various strategies analyzing the coordination compounds interacting with viruses using different processes such as wrapping viruses, rapid detection of RNA or DNA virus, or nanocarriers. These recent and novel insights help to study viruses from other points of view, allowing to measure their physical and chemical properties. We also highlight a section in which the issue of viruses from a disinfection viewpoint is addressed, using coordination compounds as a tool able to control the release of antiviral and biocide agents. This is an emerging and promising field but this approach is actually little developed. We finally provide a section with a general conclusion and perspectives.

Entities:  

Year:  2021        PMID: 33496298     DOI: 10.1039/d0dt04066e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

Review 1.  Metal-Based Compounds in Antiviral Therapy.

Authors:  Chiara Abate; Federica Carnamucio; Ottavia Giuffrè; Claudia Foti
Journal:  Biomolecules       Date:  2022-07-03

2.  Dicopper(II)-EDTA Chelate as a Bicephalic Receptor Model for a Synthetic Adenine Nucleoside.

Authors:  María Eugenia García-Rubiño; Antonio Matilla-Hernández; Antonio Frontera; Luis Lezama; Juan Niclós-Gutiérrez; Duane Choquesillo-Lazarte
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.